2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 10, 2003, Pages 2183-2192

  Van Tilburg, Erica W ^a,b   Gremmen, Matty ^a   Von Frijtag Drabbe Künzel, Jacobien ^a   De Groote, Miriam ^a   IJzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1 HEXENYL)ADENOSINE; 2 (1 HEXYNYL) 8 METHYLAMINOADENOSINE; 2 (1 HEXYNYL) 8 PROPYLAMINOADENOSINE; 2 (1 HEXYNYL)ADENOSINE; 2 IODOADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; AMINO ACID DERIVATIVE; CHEMICAL COMPOUND; CYCLIC AMP; PARTIAL AGONIST; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHO CELL; COMPARATIVE STUDY; DRUG BINDING; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; MOLECULAR WEIGHT; NONHUMAN; RAT;

EID: 0037447903     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00123-8     Document Type: Article

References (42)

1. Ralevic V., Burnstock G. Pharmacol. Rev. 50:1998;413.
2. Jacobson, K. A.; Knutsen, L. J. S. In Handbook of Experimental Pharmacology, Vol. 151/1: Purinergic and Pyrimidinergic Signalling I; Abbracchio, M. P., Williams, M., Eds: Springer-Verlag, Berlin, Germany, 2001; p 129.
3. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., Reppert S.M. Mol. Brain Res. 14:1992;186.
4. Ferré S., von Euler G., Johansson B., Fredholm B.B., Fuxe K. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7238.
5. Sullivan G.W., Linden J. Drug Dev. Res. 45:1998;103.
6. Broadley K.J. Expert Opin. Ther. Pat. 10:2000;1669.
7. IJzerman A.P., Van der Wenden E.M., Von Frijtag Drabbe Künzel J.K., Mathôt R.A.A., Danhof M., Borea P.A., Varani K. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;638.
8. Lorenzen A., Sebastiao A.M., Sellink A., Vogt H., Schwabe U., Ribeiro J.A., IJzerman A.P. Eur. J. Pharmacol. 334:1997;299.
9. Van der Graaf P.H., Van Schaick E.A., Visser S.A.G., De Greef H.J.M.M., IJzerman A.P., Danhof M. J. Pharmacol. Exp. Ther. 290:1999;702.
10. Van Tilburg E.W., von Frijtag Drabbe Künzel J., Groote M., Vollinga R.C., Lorenzen A., IJzerman A.P. J. Med. Chem. 42:1999;1393.
11. Shryock J.C., Snowdy S., Baraldi P.G., Cacciari B., Spalluto G., Monopoli A., Ongini E., Baker S.P., Belardinelli L. Circulation. 98:1998;711.
12. Cristalli G., Eleuteri A., Vittori S., Volpini R., Lohse M.J., Klotz K.-N. J. Med. Chem. 35:1992;2363.
13. Matsuda A., Shinozaki M., Yamaguchi T., Homma H., Nomoto R., Miyasaka T., Watanabe Y., Abiru T. J. Med. Chem. 35:1992;241.
14. Vittori S., Camaioni E., Di Francesco E., Volpini R., Monopoli A., Dionisotti S., Ongini E., Cristalli G. J. Med. Chem. 39:1996;4211.
15. Van der Wenden E.M., Carnielli M., Roelen H.C.P.F., Lorenzen A., von Frijtag Drabbe Künzel J.K., IJzerman A.P. J. Med. Chem. 41:1998;102.
16. Van der Wenden E.M., von Frijtag von Drabbe Künzel J.K., Mathôt R.A.A., Danhof M., IJzerman A.P., Soudijn W. J. Med. Chem. 38:1995;4000.
17. Van der Wenden E.M., Hartog-Witte H.R., Roelen H.C.P.F., Von Frijtag Drabbe Künzel J.K., Pirovano I.M., Mathôt R.A.A., Danhof M., Van Aerschot A., Lidaks M.J., IJzerman A.P., Soudijn W. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 290:1995;189.
18. Roelen H., Veldman N., Spek A.L., von Frijtag Drabbe Künzel J., Mathot R.A., IJzerman A.P. J. Med. Chem. 39:1996;1463.
19. Van Schaick E.A., Tukker H.E., Roelen H.C.P.F., IJzerman A.P., Danhof M. Br. J. Pharmacol. 124:1998;607.
20. Robins M.J., Uznanski B. Can. J. Chem. 59:1981;2601.
21. Ikehara M., Uesugi S., Kaneko M. J. Chem. Soc. Chem. Comm. 1967;17.
22. Lin T.-S., Cheng J.-C., Ishiguro K., Sartorelli A.C. J. Med. Chem. 28:1985;1481.
23. Chattopadyaya J.B., Reese C.B. Synthesis. 1977;725.
24. Volpini R., Costanzi S., Lambertucci C., Vittori S., Lorenzen A., Klotz K.-N., Cristalli G. Bioorg. Med. Chem. Lett. 11:2001;1931.
25. Francis J.E., Webb R.L., Ghai G.R., Hutchison A.J., Moskal M.A., deJesus R., Yokoyama R., Rovinski S.L., Contardo N., Dotson R., Barclay B., Stone G.A., Jarvis M.F. J. Med. Chem. 34:1991;2570.
26. Camaioni E., DiFrancesco E., Vittori S., Volpini R., Cristalli G. Bioorg. Med. Chem. 5:1997;2267.
27. Homma H., Watanabe Y., Abiru T., Murayama T., Nomura Y., Matsuda A. J. Med. Chem. 35:1992;2881.
28. Keeling S.E., Albinson F.D., Ayres B.E., Butchers P.R., Chambers C.L., Cherry P.C., Ellis F., Ewan G.B., Gregson M., Knight J., Mills K., Ravenscroft P., Reynolds L.H., Sanjar S., Sheehan M.J. Bioorg. Med. Chem. Lett. 10:2000;403.
29. Klotz K.-N., Camaioni E., Volpini R., Kachler S., Vittori S., Cristalli G. Naunyn-Schmiedeberg's Arch. Pharmacol. 360:1999;103.
30. Vittori S., Camaioni E., Constanzi S., Volpini R., Klotz K.-N., Cristalli G. Nucleosides Nucleotides. 18:1999;739.
31. Volpini R., Camaioni E., Costanzi S., Vittori S., Klotz K.-N., Cristalli G. Nucleosides Nucleotides. 18:1999;2511.
32. Volpini R., Costanzi S., Lambertucci C., Taffi S., Vittori S., Klotz K.-N., Cristalli G. J. Med. Chem. 45:2002;3271.
33. Cristalli G., Camaioni E., DiFrancesco E., Eleuteri A., Vittori S., Volpini R. Nucleosides Nucleotides. 16:1997;1379.
34. Gao, Z.-G. Allosteric Modulation of G Protein-coupled Receptors', 2000. Leiden University, Leiden, The Netherlands, 2000; pp 113.
35. Bruns R.F. Can. J. Phys.iol. Pharmacol. 58:1980;673.
36. Jacobson, K. A. In Comprehensive Medicinal Chemistry, Vol. 3: Membranes & Receptors; Emmet, J. C., Ed.; Pergamon: Oxford, New York, 1990; p 601.
37. van Galen P.J.M., Van Bergen A.H., Gallo-Rodriquez C., Melman N., Olah M.E., IJzerman A.P., Stiles G.L., Jacobson K.A. Mol. Pharmacol. 45:1994;1101.
38. Van Tilburg E.W., von Frijtag Drabbe Künzel J., de Groote M., IJzerman A.P. J. Med. Chem. 45:2002;420.
39. Pirovano I.M., IJzerman A.P., van Galen P.J.M., Soudijn W. Eur. J. Pharmacol. 172:1989;185.
40. Gao Z.-G., IJzerman A.P. Biochem. Pharmacol. 60:2000;669.
41. Olah M.E., Gallo-Rodriquez C., Jacobson K.A., Stiles G.L. Mol. Pharmacol. 45:1994;978.
42. Liu, G.-S.; Downey, J. M.; Cohen, M. V. In Purinergic Approaches in Experimental Therapeutics: Jacobson, K. A., Jarvis, M. F., Eds.; Wiley-Liss: New York, 1997; p 153.